SPAC Switcheroo

Welcome to the Daily Dish. We are your morning briefing for the SPAC market. Every day we'll provide you a digest of the top headlines of the previous day and an outline of the day ahead.

Two new deals are announced in what is turning out to be an eventful week for SPACs. In today's dish, an oncology-focused drug developer who previously broke off a SPAC merger gets a rebound SPAC, and a psychedelic-focused biopharmaceutical company looks to make its experimental treatment mainstream. Read on to find out the latest about all things SPACs. 

Read more

Source: SPAC Switcheroo